President
The administration on Thursday unveiled a new framework for US agencies to use so-called march-in rights. This would allow authorities to take over the patent of some drugs that were developed with the help of taxpayer dollars and then license the invention to another entity. This step would be taken if the drug prices are deemed to be too high.
Senior ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.